Navigation Links
Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
Date:9/20/2008

ple sclerosis.

The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. Betaseron should be used with caution in patients with depression. Injection-site necrosis has been reported in four percent of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information. More information, including the full Prescribing Information, is available at http://www.betaseron.com.

About Multiple Sclerosis

MS is a chronic, progressive disease of the central nervous system and the likelihood of disability increases the longer someone has MS. Symptoms of MS vary from person to person and can be unpredictable. They may include: fatigue or tiredness, dimness of vision in one or both eyes, weakness in one or more extremities, numbness and tingling in the face, arms, legs and trunk of the body, spasticity (muscle stiffness), dizziness, double vision, slurred speech and loss of bladder control.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, General Medicine, which includes Cardiology and Primary Car
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
5. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
6. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
7. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
8. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
9. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
10. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
11. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... PAREXEL International Corporation (NASDAQ: PRXL ) announced ... Conference on Monday, May 18, 2015, in New York City.  ... Officer will be making a presentation on PAREXEL and discussing ... webcast of the presentation will be available through the "Investors" ... Upcoming Events portion of the main page, and a replay ...
(Date:5/4/2015)... May 4, 2015  Makindus, Inc. a specialty pharmaceutical ... European Medicines Agency (EMA) has granted orphan drug designation ... Stargardt,s Disease. "We are extremely pleased to ... Stargardt,s disease in place for Europe ... the United States for which ...
(Date:5/4/2015)... BUFFALO, N.Y. , May 4, 2015 /PRNewswire/ ... Stephanie Englert , PharmD, has completed preliminary analysis ... Disorder and Schizophrenia. Resources from Clinical Support Services, ... Medication Reviews (CMR) with patients currently taking psychiatric ... events. The research found that 93% of patients ...
Breaking Medicine Technology:PAREXEL International to Present at UBS Healthcare Conference 2European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 3
... 28 NeurogesX, Inc. (Nasdaq: NGSX ), ... pain management therapies, announced today that Anthony DiTonno, President ... the 21st Annual Oppenheimer & Co Healthcare Conference, to ... New York, NY. Mr. DiTonno and ...
... Oct. 28 See video from AstraZeneca ... Anglo-Swedish pharmaceutical company AstraZeneca announced ... by 2% at constant exchange rates (CER) ... at CER for Crestor, Symbicort and Seroquel ...
Cached Medicine Technology:NeurogesX to Present at Oppenheimer & Co Healthcare Conference 2NeurogesX to Present at Oppenheimer & Co Healthcare Conference 3
(Date:5/4/2015)... May 04, 2015 McNeil & ... announces the expansion of coverage for its Emergency ... provider of industry-tailored insurance and proactive risk management to ... we are dedicated to providing our customers with unparalleled ... many evolving needs. We are excited to launch over ...
(Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – the ... lymphoma research and serving the lymphoma community through a ... services – is set to host its annual Ace ... Orange, NJ on June 1, 2015. Since 2010, the ... through LRF. , This year, the Lymphoma Research Foundation ...
(Date:5/4/2015)... 04, 2015 METTLER TOLEDO has ... of Data Integrity in a GXP Regulated Laboratory ... presenter. This webinar will be presented on May ... Data integrity is a critical component of pharmaceutical ... agencies. However, in recent years an increasing number ...
(Date:5/4/2015)... City, OK and Seattle, WA (PRWEB) May 04, 2015 ... announced the formation of a collaboration to facilitate development ... number of ophthalmic disorders that lead to blindness, including ... to the MiDROPS™ formulation platform developed by EyeCRO, which ... the eye via a topical eyedrop. , Under ...
(Date:5/4/2015)... CCL, a top-ranked, global provider of leadership ... other leadership development consultancies. “The CCL Partner Network ... practitioners, expanding our capacity to drive results for individual ... Ryan, CCL President and CEO. , As soon as ... , it will schedule a one-on-one conference with a ...
Breaking Medicine News(10 mins):Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2
... Report finds youngsters worse off than adults; biggest gaps found ... Kids in the United States aren,t getting the health care ... study shows. , "Children in the U.S. receive only 46 ... they receive worse care than adults in this country, who ...
... tick movement; ... WESTBROOK, Maine, Oct. 10 Ticks have long posed both ... Northeast, but this,fall, new areas of the country may experience ... active during the fall months,and data compiled by the veterinary ...
... 10 Health and nutrition researcher,Kimberly Day tested ... the,market to determine if they are delivering the ... samples of MonaVie, Xango, and Thai-Go to Brunswick,Laboratories, ... The drinks were tested to determine their ORAC ...
... and gene ... therapy -, PHILADELPHIA, ... Katherine A. High,M.D., has been elected to the Institute of Medicine. Dr. ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071010/DCW020 ) The Institute of Medicine (IOM) today ...
... ... Foundation, SAN FRANCISCO, Oct. 10 ... (Oct. 10) the,creation of an innovative national training, awareness and action program,to ... The program will be funded through a $300,000 grant from the ...
... and Organ,Transplantation, WASHINGTON, Oct. 10 The National Kidney,Foundation ... Annual,Kidney Walk on Saturday, October 13, 2007. Registration begins at ... or 1K walk along the scenic C&O,Canal in Georgetown will ... 3222 M Street NW in Washington, DC., The Walk ...
Cached Medicine News:Health News:U.S. Kids Not Getting Needed Health Care 2Health News:U.S. Kids Not Getting Needed Health Care 3Health News:U.S. Kids Not Getting Needed Health Care 4Health News:Migrating Tick Populations Pose Year-Round Disease Threat for People and Pets 2Health News:Migrating Tick Populations Pose Year-Round Disease Threat for People and Pets 3Health News:Children's Hospital Physician Elected to Institute of Medicine 2Health News:World Institute on Disability and American Red Cross Partner to Provide Innovative Training to Better Assist Those With Disabilities 2Health News:World Institute on Disability and American Red Cross Partner to Provide Innovative Training to Better Assist Those With Disabilities 3Health News:World Institute on Disability and American Red Cross Partner to Provide Innovative Training to Better Assist Those With Disabilities 4Health News:The National Kidney Foundation's 6th Annual Kidney Walk to Be Held on Saturday, October 13 2Health News:The National Kidney Foundation's 6th Annual Kidney Walk to Be Held on Saturday, October 13 3
... drugs of abuse tests are highly accurate in ... recommended cut-off as confirmed by GC/MS testing. This ... specific alternative method (such as GC/MS) must be ... Professional judgment should be applied to any drug ...
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
... bottle becomes preservative-free on eye contactits ... and water on eye contact. It ... to moderate dryness or eyes that ... you can have the benefits of ...
... Contact Lens Comfort Drops improve comfort on contact ... contact lenses from your disinfecting system or from ... your finger and place one or two drops ... it in your eyethe lens will go in ...
Medicine Products: